Ramaraj Radhakrishnan, Sorrell Vincent L, Movahed Mohammad Reza
Department of Medicine, Section of Cardiology, University of Arizona School of Medicine, Southern Arizona VA Health Care System, Tucson, Arizona, USA.
Exp Clin Cardiol. 2009 Spring;14(1):6-8.
Stress-induced cardiomyopathy is usually associated with an increased level of cardiac enzymes, leading to difficulties in differentiating this condition from acute coronary syndrome. The final diagnosis is usually made based on angiographic findings revealing normal coronary arteries. It was hypothesized that maximal cardiac enzyme elevation in these patients should have an upper limit. In the present study, reported cases of stress cardiomyopathy were compared with documented cardiac enzyme levels to evaluate the upper cut-off point of troponin in this population.
All of the articles published in PubMed and MEDLINE from November 2007 to July 2008, on takotsubo or stress-induced cardiomyopathy, were identified. Only the cases that reported the absolute or mean level of cardiac enzymes were included. The level of various enzymes were correlated with cardiac function, and the upper limit of enzyme elevation was calculated in these patients.
A total of 114 patients (mean [+/- SD] age 63.5+/-14.5 years) were included in the study. Seventy-one per cent of the patients were older than 50 years of age and 86% were female. Mean values for troponin I, troponin T, creatine kinase (CK) and CK-MB were 6.5 ng/mL, 3.6 ng/mL, 556 U/L and 32.9 U/L, respectively. All of the patients with takotsubo cardiomyopathy had a troponin T level of 6 ng/mL or less and troponin I level of 15 ng/mL or less. Troponin T showed a significant inverse correlation with initial ejection fraction (R(2)=0.6), which was not seen with the levels of troponin I, CK and CK-MB. Takotsubo cardiomyopathy was classified as classic (66.7%), mid-cavitary (10%), reverse (23.3%) or local (0%).
Among patients with takotsubo cardiomyopathy, troponin T level correlated with initial ejection fraction. Furthermore, the diagnosis of takotsubo cardiomyopathy appears to be unlikely in patients with troponin T greater than 6 ng/mL or troponin I greater than 15 ng/mL.
应激性心肌病通常与心肌酶水平升高相关,这导致难以将该病症与急性冠状动脉综合征区分开来。最终诊断通常基于冠状动脉造影显示冠状动脉正常的结果。据推测,这些患者心肌酶的最大升高应有一个上限。在本研究中,将报道的应激性心肌病病例与记录的心肌酶水平进行比较,以评估该人群中肌钙蛋白的上限值。
检索2007年11月至2008年7月在PubMed和MEDLINE上发表的所有关于应激性心肌病或章鱼壶心肌病的文章。仅纳入报告了心肌酶绝对水平或平均水平的病例。将各种酶的水平与心功能相关联,并计算这些患者酶升高的上限。
共有114例患者(平均年龄[±标准差]63.5±14.5岁)纳入研究。71%的患者年龄大于50岁,86%为女性。肌钙蛋白I、肌钙蛋白T、肌酸激酶(CK)和CK-MB的平均值分别为6.5 ng/mL、3.6 ng/mL、556 U/L和32.9 U/L。所有应激性心肌病患者的肌钙蛋白T水平均在6 ng/mL或以下,肌钙蛋白I水平在15 ng/mL或以下。肌钙蛋白T与初始射血分数呈显著负相关(R² = 0.6),而肌钙蛋白I、CK和CK-MB的水平未显示出这种相关性。应激性心肌病分为典型型(66.7%)、心腔中部型(10%)、倒转型(23.3%)或局限型(0%)。
在应激性心肌病患者中,肌钙蛋白T水平与初始射血分数相关。此外,肌钙蛋白T大于6 ng/mL或肌钙蛋白I大于15 ng/mL的患者似乎不太可能诊断为应激性心肌病。